ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      97,832.95
      -0.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Tarkett (TKTT) Quote

      Tarkett

      Tarkett (TKTT)

      EU
      10.50
      0.05
      (0.48%)
      Closed January 05 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      10.50
      Bid
      10.45
      Ask
      10.65
      Volume
      2,715
      10.45 Day's Range 10.55
      8.32 52 Week Range 11.35
      Market Cap
      687.13M
      Previous Close
      10.45
      Open
      10.45
      Last Trade
      1
      @
      10.5
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      11,661
      Shares Outstanding
      65,440,971
      Dividend Yield
      -
      PE Ratio
      33.69
      Earnings Per Share (EPS)
      0.31
      Revenue
      3.36B
      Net Profit
      20.4M

      About Tarkett

      Sector
      Floor Layng,oth Floorwk, Nec
      Industry
      Floor Layng,oth Floorwk, Nec
      Website
      www.tarkett-group.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Tarkett is listed in the Floor Layng,oth Floorwk sector of the Euronext with ticker TKTT. The last closing price for Tarkett was 10.45 €. Over the last year, Tarkett shares have traded in a share price range of 8.32 € to 11.35 €.

      Tarkett currently has 65,440,971 shares outstanding. The market capitalization of Tarkett is 683.86 € million. Tarkett has a price to earnings ratio (PE ratio) of 33.69.

      Ask ADVFN Intelligence (AI)

      TKTT Latest News

      More News

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 31 décembre 2024

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 31 décembre 2024 PARIS, 03 Janvier 2025 — Information relative au nombre...

      January 03 2025
      UK Regulatory

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of December, 31st, 2024

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of December, 31st, 2024 PARIS, FRANCE, January 3rd, 2025 - Information on the total number of...

      January 03 2025
      UK Regulatory

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 30 novembre 2024

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 30 novembre 2024 PARIS, 02 Décembre 2024 — Information relative au nombre...

      December 02 2024
      UK Regulatory

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of November, 30th, 2024

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of November, 30th, 2024  PARIS, FRANCE, December 2nd, 2024 - Information on the total number of...

      December 02 2024
      UK Regulatory

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 31 Octobre 2024

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 31 Octobre 2024    PARIS, 04 Novembre 2024 — Information relative au nombre...

      November 04 2024
      UK Regulatory

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of October, 31st, 2024

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of October, 31st, 2024 PARIS, FRANCE, November 4th, 2024 - Information on the total number of...

      November 04 2024
      UK Regulatory

      Q3 2024 Revenue: Solid organic sales growth of +2.4% Sports division grew at a sustained pace in the most important quarter of the year. Activity remained sluggish in flooring, particularly in EMEA and the CIS countries

      Q3 2024 Revenue: Solid organic sales growth of +2.4% Sports division grew at a sustained pace in the most important quarter of the year. Activity remained sluggish in flooring, particularly in...

      October 18 2024
      UK Regulatory

      hiffre d’affaires du T3 2024 : Solide croissance organique des ventes de +2,4% La division Sport croît à un rythme soutenu au cours du trimestre le plus important de l’année. L’activité reste atone dans les revêtements de sol, en particul

      hiffre d’affaires du T3 2024 : Solide croissance organique des ventes de +2,4% La division Sport croît à un rythme soutenu au cours du trimestre le plus important de l’année. L’activité reste...

      October 18 2024
      UK Regulatory

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 30 septembre 2024

      Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 30 septembre 2024 PARIS, 02 Octobre 2024 — Information relative au nombre...

      October 02 2024
      UK Regulatory

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of September, 30th, 2024

      Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of September, 30th, 2024 PARIS, FRANCE, October 2nd, 2024 - Information on the total number of...

      October 02 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.3-2.7777777777810.810.8510.3383910.56509508DE
      40.43.960396039610.110.9510.05436910.56377474DE
      121.3214.37908496739.1811.359.161166110.43009332DE
      262.0223.8207547178.4811.358.34665710.1330476DE
      521.2213.14655172419.2811.358.3247299.87314779DE
      156-8.72-45.369406867819.2219.78.32481211.60535155DE
      260-3.84-26.778242677814.3421.47.533469313.61225566DE

      TKTT - Frequently Asked Questions (FAQ)

      What is the current Tarkett share price?
      The current share price of Tarkett is 10.50 €
      How many Tarkett shares are in issue?
      Tarkett has 65,440,971 shares in issue
      What is the market cap of Tarkett?
      The market capitalisation of Tarkett is EUR 683.86M
      What is the 1 year trading range for Tarkett share price?
      Tarkett has traded in the range of 8.32 € to 11.35 € during the past year
      What is the PE ratio of Tarkett?
      The price to earnings ratio of Tarkett is 33.69
      What is the cash to sales ratio of Tarkett?
      The cash to sales ratio of Tarkett is 0.2
      What is the reporting currency for Tarkett?
      Tarkett reports financial results in EUR
      What is the latest annual turnover for Tarkett?
      The latest annual turnover of Tarkett is EUR 3.36B
      What is the latest annual profit for Tarkett?
      The latest annual profit of Tarkett is EUR 20.4M
      What is the registered address of Tarkett?
      The registered address for Tarkett is TOUR INITIALE 1 TERRASSE BELLINI, PARIS, PARIS, 92919
      What is the Tarkett website address?
      The website address for Tarkett is www.tarkett-group.com
      Which industry sector does Tarkett operate in?
      Tarkett operates in the FLOOR LAYNG,OTH FLOORWK, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLFXOFinaxo
      0.895 €
      (43.20%)
      		500
      MLWEYWeya
      0.0175 €
      (34.62%)
      		5.1k
      POXELPoxel
      0.191 €
      (33.57%)
      		4.22M
      ALBIOBiosynex
      2.50 €
      (28.73%)
      		50.71k
      SEQUASequana medical NV
      3.02 €
      (23.27%)
      		1.05M
      BNBSTonner Drones
      0.0005 €
      (-50.00%)
      		524.03k
      ALAGOEPango SA
      0.127 €
      (-41.20%)
      		11.94M
      EIFDSTour Eiffel DS
      0.0032 €
      (-38.46%)
      		33.94k
      FINMFinanciere Marjos
      0.076 €
      (-36.13%)
      		1.4k
      ALALOAcheterLouerFR
      0.20 €
      (-33.33%)
      		90.63k
      ATOAtos SE
      0.0024 €
      (-4.00%)
      		1.53B
      BCPBanco Comercial Portugues SA
      0.4623 €
      (0.74%)
      		43.69M
      ALTDTonner Drones
      0.0118 €
      (-7.81%)
      		27.49M
      NEOENNeoen SA
      39.74 €
      (-0.15%)
      		21.76M
      ALVERVergnet
      0.002 €
      (0.00%)
      		16.8M

      Discussion

      View Full Feed
      Red Cloud Red Cloud 25 seconds ago
      Thanks so much for your response

      I'll look for the text of those Warrant Agreements
      FNMA
      fuagf fuagf 40 seconds ago
      Flip flop artist Trump is a flip, and sadly will most likely be a flop as president again.

      https://www.usnews.com/object/image/00000194-1e6c-d7ea-a1d5-5fee8e950000/20241231ednac-a.jpg?update-time=1735677640116&size=responsiveGallery
      barnyarddog barnyarddog 41 seconds ago
      . NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.



      https://www.linkedin.com/company/nrx-pharma/
      NRXP
      Debunkinator Debunkinator 50 seconds ago
      Short sellers down $180.9B in 2024 mark-to-market losses as Wall Street soars
      LMAO--$$$$ Weeeeeeeeeeeeeeeeeeeeeeeee
      ASII
      attilathehunt attilathehunt 1 minute ago
      Somewhere in Bethesda....


      Ring-a-ding-a-ring...

      LP: Hello, this is Linda.

      RD: Good morning Linda. This is Rob( Rob Davis, CEO of Merck)...

      LP: Oh, hi Rob! I was expecting your call as soon as we received approval from the MHRA.
      DJT NWBO
      JR30 JR30 1 minute ago
      Shorty still crying when the SP is doing well.
      VERB
      dstock07734 dstock07734 1 minute ago
      I thought about the same thing. The only difference is that in my version Merck is the one who does the BLA submission to FDA. Just like what happened to the Daiichi's ADC. Here is the trial with Merck as collaborator. In October 2023, Merck and Daiichi struck the deal on three ADCs including the pl
      NWBO
      GetSeriousOK GetSeriousOK 2 minutes ago
      OTC is entering a golden age in 2024 - Chartmaster.
      OTC is entering a golden age in 2023 - Chartmaster.
      OTC is entering a golden age in 2022 - Chartmaster.
      I'm a genius and a millionaire - Chartmaster.

      You know what they call that guy on every other board, don't y
      BIEL
      Monksdream Monksdream 2 minutes ago
      HUH! Who wants to bet AAPL doesn’t make another new high in 2025
      https://investorshub.advfn.com/uimage/uploads/2025/1/5/fngepIMG_4473.gif
      AAPL
      Involuntary-Recluse Involuntary-Recluse 3 minutes ago
      Lmao, if only it worked that way T 😂
      zab zab 3 minutes ago
      I remember the real estate deferral tax deduction. I know I did not say it correctly,  but there is nothing better than claiming tax deduction on losses or gains in the future,  and using it to shield income. 
      Hopeforthefuture3 Hopeforthefuture3 5 minutes ago
      Eagle, imo good comparison in your post. One other item is that Kazia with paxalisib is part of the gbm AGILE program. As part of this they do have a patient level data control group. The program has 5 companies testing 5 different treatments and 1 soc control group to use as comparison with patient
      NWBO
      Zorax Zorax 6 minutes ago
      Stupid Gets what Stupid Dose

      Kind of ironic isn't it, using the wrong word about stupidity? lmao.

      But then again, this just shows the tower of stupidity of trolls. I'd say the first 78 floors are empty of intelligence and the final 22 floors are just pure evil.
      TURCH TURCH 8 minutes ago
      Im ready for your long term play find it 😁


      Regards 
      marcis marcis 8 minutes ago
      Ok Orlando Taddeo and his management is lying

      Got it

      Next
      RDAR
      skitahoe skitahoe 9 minutes ago
      Market Beats article on AVXL

      https://www.marketbeat.com/originals/short-squeeze-target-anavex-life-sciences-gains-traction/

      I don't think anyone here posted this, it's complementary, but they're also pushing other stocks if you follow their link, which I didn't. I beli
      AVXL JPM
      JamesF1 JamesF1 10 minutes ago
      Nasrat said on the last conference call that Elite sold their entire quota of Adderall. We don’t know if/when they obtained more quota. If they lost some market share on Adderall that is why. Vyvanse sales will almost all be in the current quarter, so February’s numbers MIGHT not be as impressiv
      ELTP
      jcromeenes jcromeenes 10 minutes ago
      Yet January 16 looks to the the "exciting" day 😀
      FNMA
      John Doe 2024 John Doe 2024 10 minutes ago
      It's none of their business what you funded or not. We can agree or disagree and argue on here but that's nobody's business but yours what you sold or didn't sell or funded.
      XERI
      mineanddine mineanddine 10 minutes ago
      Noting that HIRU is a confirmed scam 
      HIRU
      surfkast surfkast 11 minutes ago
      Obviously you did not even read the website. SMH
      HMBL
      BDEZ BDEZ 11 minutes ago
      Exactly, wonder if that can be overturned by Executive order?
      Samuel J Samuel J 11 minutes ago
      One more thing Mr. PROBLEM with the none stop Calandar, tell me one CEO that is in the OTC that communicates as much as Josh, with a ticket on NASDAQ and a few in the OTC? 

      Name me one ☝️ 

      Laughable!
      AZRH
      FOFreddie FOFreddie 12 minutes ago
      HI Red Cloud - Take a look at the Warrant Agreement - personally I did not see an anti-dilution provision but not sure. You can access from the websites - I have previously posted them so perhaps others have access to the Agreements. It would seem that the biggest dilution risk comes with earli
      DJT

      Your Recent History

      EU
      TKTT
      Tarkett
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads